Health Catalyst, Inc.

Equities

HCAT

US42225T1079

Software

Market Closed - Nasdaq 04:00:00 2024-07-05 pm EDT 5-day change 1st Jan Change
6.19 USD +0.16% Intraday chart for Health Catalyst, Inc. -3.13% -33.15%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell 3000E Index CI
Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell Microcap Index CI
Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell Microcap Growth Index CI
Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell 3000E Growth Index CI
Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell Microcap Value Index CI
Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell 3000E Value Index CI
Health Catalyst Closes Acquisition of Carevive Systems MT
Piper Sandler Trims Price Target on Health Catalyst to $14 From $15, Maintains Overweight Rating MT
Health Catalyst, Inc. acquired Carevive Systems, Inc. CI
Health Catalyst, Inc Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite® CI
Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating MT
Health Catalyst Seeks M&A CI
Health Catalyst, Inc. Provides Revenue Guidance for the Second Quarter and Reiterates Revenue Guidance for the Full Year of 2024 CI
Transcript : Health Catalyst, Inc., Q1 2024 Earnings Call, May 09, 2024
Earnings Flash (HCAT) HEALTH CATALYST Posts Q1 Revenue $74.7M, vs. Street Est of $74.8M MT
Earnings Flash (HCAT) HEALTH CATALYST Posts Q1 EPS $0.05, vs. Street Est of $0.03 MT
Health Catalyst, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Health Catalyst, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 CI
North American Morning Briefing : Stock Futures -2- DJ
KeyBanc Downgrades Health Catalyst to Sector Weight From Overweight on Potential Risks to Hospital End Markets MT
North American Morning Briefing : Traders Await -2- DJ
Transcript : Health Catalyst, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 10:15 AM
Health Catalyst Shares Rise After CEO Stock Purchase MT
Transcript : Health Catalyst, Inc. - Special Call
KeyBanc Cuts Price Target on Health Catalyst to $10 From $12, Keeps Overweight Rating MT
Chart Health Catalyst, Inc.
More charts
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company’s solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
6.19 USD
Average target price
11.43 USD
Spread / Average Target
+84.63%
Consensus
1st Jan change Capi.
-33.15% 365M
-3.06% 256B
-17.00% 60.79B
+3.19% 60.22B
+1.80% 53.42B
+10.86% 45.01B
+1.06% 36.74B
-8.72% 28.92B
+117.82% 28.56B
+6.57% 22.33B
Application Software
  1. Stock Market
  2. Equities
  3. HCAT Stock
  4. News Health Catalyst, Inc.
  5. KeyBanc Cuts Price Target on Health Catalyst to $10 From $12, Keeps Overweight Rating